Adverse Events of Lutetium-177-PSMA-617 Revealed
Lutetium-177-PSMA-617 (Pluvicto®) has emerged as a groundbreaking radiolabeled therapeutic agent in the battle against advanced prostate cancer, specifically targeting metastatic ...
Tag: metastatic castration-resistant prostate cancer
PDGFC Promotes Enzalutamide Resistance via Rap1-MAPK Pathway
In recent advancements in the field of oncology, a study led by Deng, Chen, and Zhong has unveiled a significant ...
Unraveling SOX2: Its Crucial Role in Prostate Cancer Progression and Therapy Resistance
Prostate cancer persists as a formidable global health adversary, ranking as the second most prevalent malignancy in men worldwide. While ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!